CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-07 | Prasad Raju Chief Financial Officer | Gift | −750 | 14,815 | ||
| 2026-05-29 | Prasad Raju Chief Financial Officer | Grant or award · Restricted Stock Units | +19,500 | 19,500 | ||
| 2026-03-23 | Prasad Raju Chief Financial Officer | Sale | −3,708 | $46.78 | $173K | 15,565 |
| 2026-03-20 | Prasad Raju Chief Financial Officer | Exercise or conversion | +6,250 | 19,273 | ||
| 2026-03-20 | Prasad Raju Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +38,499 | 38,499 | ||
| 2026-03-20 | Prasad Raju Chief Financial Officer | Grant or award · Restricted Stock Units | +27,500 | 27,500 | ||
| 2026-03-20 | Prasad Raju Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −6,250 | 12,500 | ||
| 2026-03-16 | Prasad Raju Chief Financial Officer | Sale | −5,848 | $48.26 | $282K | 17,794 |
| 2026-03-16 | Prasad Raju Chief Financial Officer | Sale | −4,021 | $48.26 | $194K | 13,773 |
| 2026-03-16 | Prasad Raju Chief Financial Officer | Gift | −750 | 13,023 | ||
| 2026-03-14 | Prasad Raju Chief Financial Officer | Exercise or conversion | +10,000 | 16,767 | ||
| 2026-03-14 | Prasad Raju Chief Financial Officer | Exercise or conversion | +6,875 | 23,642 | ||
| 2026-03-14 | Prasad Raju Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −10,000 | 10,000 | ||
| 2026-03-14 | Prasad Raju Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −6,875 | 20,625 | ||
| 2026-01-22 | Prasad Raju Chief Financial Officer | Exercise or conversion 10b5-1 | +34,972 | $45.15 | $1.6M | 41,739 |
| 2026-01-22 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −34,972 | $60.19 | $2.1M | 6,767 |
| 2026-01-22 | Prasad Raju Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −34,972 | 41,667 | ||
| 2026-01-06 | Prasad Raju Chief Financial Officer | Exercise or conversion 10b5-1 | +23,361 | $45.15 | $1.1M | 30,128 |
| 2026-01-06 | Prasad Raju Chief Financial Officer | Exercise or conversion 10b5-1 | +6,339 | $44.31 | $281K | 36,467 |
| 2026-01-06 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −18,933 | $60.18 | $1.1M | 17,534 |
Page 1 of 3 · 47 trades